KMT2A and acute myeloid leukemia: A highly context-dependent function of Ezh2 has come to light in a recent work by Basheer et al., where Ezh2 deletion prior to retroviral transduction with oncogenic MLL-AF9 accelerated disease development and shortened survival in mouse models of acute myeloid leukemia (AML).[4].